home > Venture capital > Portfolio > Life sciences

Investments in Life Sciences





Investments in Life Sciences

Drug discovery based on peptide aptamer technology
Diagnosis of allergies and autoimmune diseases
Development of customized meganucleasis for rational genome engineering
Anti-cancer therapy discovery and development using a drug delivery platform based on peptide vectors
Discovery of drugs acting against cancer and neurodegenerative diseases through the analysis of splicing events
Discovery and development of molecules for inflammatory and central nervous system diseases
French biotechnology company specialized in the encapsulation of therapeutic molecules or enzymes into red blood cells
Discovery and development of new medicine for the treatment of chronic neurodegenerative diseases
Development and marketing of predictive diagnostics for a range of complex diseases
Production of therapeutic recombinant proteins in plants for the pharmaceutical industry
Development of protein delivery systems and cell-based therapies for the treatment of ophthalmologic diseases
A biopharmaceutical company specializing in ophthalmology
Development and marketing of spinal implants and instruments
Discovery and development of peptides for metabolic disorders and cardio-vascular diseases

back